Table 1.
Factor | Group | Number of patients | Median survival (months) | 95% CI for survival | p value | |
---|---|---|---|---|---|---|
Age | < 18 years | 19 | 32 | 4 | 60 | 0.56 |
≥ 18 years | 26 | 17 | 7 | 27 | ||
Sex | Male | 30 | 52 | 17 | 87 | 0.04 |
Female | 15 | 11 | 9 | 14 | ||
Site | Extremity | 36 | 17 | 14 | 20 | 0.37 |
Pelvis | 9 | 59 | 0 | 149 | ||
Tissue | Bone | 10 | 52 | 8 | 95 | 0.99 |
Soft tissue | 35 | 17 | 14 | 20 | ||
Necrosis of primary tumor | < 90% | 28 | 15 | 9 | 21 | 0.03 |
≥ 90% | 17 | 60 | 22 | 99 | ||
Necrosis of recurrent tumor | < 50% | 14 | 52 | 0 | 108 | 0.71 |
≥ 50% | 11 | 32 | 0 | 79 | ||
Chemotherapy | Yes | 37 | 18 | 0 | 37 | 0.53 |
No | 8 | 17 | 0 | 38.5 | ||
Ifosfamide | Yes | 23 | 17 | 8 | 26 | 0.16 |
No | 14 | 60 | 0 | 151 | ||
Surgery | Limb-sparing | 13 | 32 | 6 | 57 | 0.28 |
Amputation | 18 | 17 | 13 | 21 | ||
Time to recur | < 12 months | 15 | 15 | 9 | 21 | 0.05 |
≥ 12 months | 30 | 33 | 0 | 78 | ||
Time to recur | < 24 months | 28 | 15 | 10 | 21 | 0.03 |
≥ 24 months | 17 | 52 | 4 | 100 | ||
Time period | 1985–95 | 21 | 16 | 13 | 19 | 0.97 |
1996–2007 | 24 | 32 | 0 | 68 | ||
Systemic recurrence | Local recurrence without systemic recurrence | 19 | 60 | 4 | 116 | 0.01 |
Local recurrence with systemic recurrence | 17 | 11 | 6 | 17 | ||
Local recurrence after systemic recurrence | 9 | 18 | 0 | 39 | ||
Recurrence size | < 5 cm | 9 | 84 | 44 | 124 | < 0.0001 |
≥ 5 cm | 36 | 15 | 9 | 22 |